LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecules Engineered to Treat Breast Cancer

By Biotechdaily staff writers
Posted on 15 May 2007
Investigators have identified molecules that have been shown to be successful in the fighting breast cancer. The researchers used state-of-the-art computational techniques in a novel way to modify molecules that they predicted would be effective lead compounds for breast cancer research.

The investigators, from Hamilton College (Clinton, NY, USA), then asked scientists from the Albany Medical College (Albany, NY, USA) to then synthesize the predicted molecules, which subsequently showed that they were indeed potential anti-breast cancer compounds in animal systems. The study's findings will be published in the May 16, 2007, issue of the Journal of American Chemical Society.

Breast cancer is the most common cancer among women, and tamoxifen is the preferred drug for estrogen receptor-positive breast cancer treatment. Many of these tumors are inherently resistant to tamoxifen or acquire resistance during treatment. Consequently, there is an ongoing need for breast cancer drugs that have different molecular targets.

Earlier studies by the Albany Medical College researchers had demonstrated that 8-mer and cyclic 9-mer peptides suppress breast cancer in mouse and rat models, interacting with an unsolved receptor, while peptides smaller than eight amino acids did not.

The Hamilton researchers utilized state-of-the-art computational techniques to predict the structure and dynamics of active peptides, leading to the finding of smaller peptides with full biologic activity. The results were used to identify smaller peptides with the three-dimensional structure of the larger peptides. These peptides were synthesized and shown to inhibit estrogen-dependent cell growth in a mouse uterine growth assay, a test showing correlation with human breast cancer inhibition.

The study's findings were first presented at the 2006 International Symposium on Theory and Computations in Molecular and Materials Sciences, Biology, and Pharmacology, held on St. Simon's Island, GA, USA.


Related Links:
Hamilton College
Albany Medical College

New
Gold Member
Aspiration System
VACUSAFE
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]

Latest BioResearch News

Single-Cell Method Measures RNA and Proteins to Reveal Immune Responses
15 May 2007  |   BioResearch

Study Links Midlife Vitamin D to Lower Tau in Alzheimer's
15 May 2007  |   BioResearch

International Consensus Standardizes Tumor Microbiota Detection and Reporting
15 May 2007  |   BioResearch